Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
701.48B | 660.84B | 618.90B | 516.44B | 439.41B | 468.62B | Gross Profit |
239.39B | 219.01B | 204.43B | 178.83B | 154.23B | 181.64B | EBIT |
76.08B | 73.40B | 55.37B | 50.68B | 41.67B | 39.83B | EBITDA |
99.21B | 93.72B | 80.13B | 69.92B | 62.34B | 56.59B | Net Income Common Stockholders |
62.25B | 56.44B | 43.73B | 38.90B | 31.16B | 26.83B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
26.80B | 119.16B | 103.86B | 81.77B | 61.28B | 30.09B | Total Assets |
311.18B | 667.88B | 566.38B | 503.06B | 438.51B | 387.33B | Total Debt |
92.20B | 59.91B | 50.98B | 43.46B | 41.66B | 35.35B | Net Debt |
65.54B | -59.25B | -48.36B | -35.77B | -14.02B | 5.26B | Total Liabilities |
144.09B | 169.62B | 149.42B | 139.15B | 124.99B | 109.57B | Stockholders Equity |
165.46B | 491.36B | 410.51B | 357.82B | 308.13B | 272.43B |
Cash Flow | Free Cash Flow | ||||
16.65B | 49.74B | 32.65B | 32.53B | 40.10B | 13.69B | Operating Cash Flow |
27.06B | 80.81B | 59.20B | 52.09B | 57.17B | 39.65B | Investing Cash Flow |
-11.51B | -42.99B | -26.62B | -16.11B | -16.89B | -29.23B | Financing Cash Flow |
-2.21B | -31.42B | -20.38B | -17.90B | -15.42B | -9.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$8.50B | 20.81 | 12.17% | 1.86% | ― | ― | ||
65 Neutral | $8.88B | 15.05 | 4.75% | 203.76% | 3.54% | -2.50% | |
$24.90B | 54.81 | 8.89% | 1.06% | ― | ― | ||
€2.82B | 15.97 | 9.19% | 1.96% | ― | ― | ||
69 Neutral | ¥23.70B | 37.66 | 1.98% | 0.93% | 330.14% | ||
66 Neutral | ¥260.53B | 16.54 | 1.94% | 25.63% | -24.35% | ||
64 Neutral | ¥24.06B | 18.03 | 1.74% | 6.08% | -22.00% |